1. Inter‑component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma
   Andrzej Pyra et al, 2022, Oncology Letters CrossRef
2. Role of p53 Pathway Alterations in Uterine Carcinosarcomas (Malignant Mixed Müllerian Tumors)
   Andrzej Semczuk et al, 2014, Oncology CrossRef